To document the development of new "CITH" varieties, ICAR- Central Institute of Temperate Horticulture Kashmir (India) initiated a rigorous investigation starting in 1996 under the Project "Survey, Collection, Characterization, and Documentation of Temperate Fruit Crops".
The institute has identified and collected variability from the century-old varieties Biggareau Napoleon, Bigarreau Noir Grossa, Guigne Noir Hative, etc. Currently, the institute has a germplasm bank with 30 genotypes of sweet and sour cherries.
Of these, four promising genotypes have been identified, namely, CITH-Cherry-03, CITH-Cherry-05, CITH-Cherry-07, and CITH-Cherry-09. The CITH-Sweet cherry clones, selected from the Double and Misri varieties, bear larger fruits and are attractive in shape and color with a high total soluble solids content and pulp/stone ratio. The new varieties are of good quality with high fruit set (50-80%) under normal conditions.
For more information on CITH varieties, download the PDF here
09 Oct 2025
A study in Turkey analyzed the impact of copper oxide nanoparticles (CuO-NPs) on sweet cherry (Prunus avium) germination and growth. Results revealed dose-dependent effects and population variability, relevant for reforestation in polluted forest areas.
Consumption Markets Production
30 Aug 2023
The total cherry production forecast in Türkiye in Marketing Year 2023/24 is 900,000 metric tons, which is 8% higher than MY 2022/23, due to favorable weather and soil conditions. As of early August 2023, cherry exports have reached 75,000 MT, on track to surpass the previous MY.
03 Apr 2026
A study examines the impact of soil salinity on sweet cherry by comparing MaxMa 14 and Gisela 6 rootstocks. Differences in growth, biomass, and salt stress tolerance provide practical guidance for improving orchard resilience and long-term productivity.
03 Apr 2026
Dark sweet cherries improve gut microbiota, reduce inflammation, and support memory and focus. Scientific studies highlight benefits for metabolism and cognitive health, especially in higher-risk individuals and widespread metabolic conditions, with growing scientific validation.
